Interleukin-2 Inc said theregistration of warrants became effective March 20 and that 3.5
mln warrants will be convertible into 1.75 mln shares of the
company's common stock, giving the company a maximum of 2.4 mln
dlrs.
    The warrants must be exercised by June 22.
 Reuter
